Search results
Results from the WOW.Com Content Network
The 5-year relative survival rate for chronic lymphocytic leukemia (CLL) among adults ages 20 or older is 87%. Although the condition is typically incurable, a person can live with this form of...
About half of people with CLL survive for at least 10 years, but the survival period can range from 2 years to more than 20 years. Doctors often use 5-year relative survival rates to report...
The prognosis for CLL is much higher than for many other types of cancer. However, there is currently no cure for this disease. CLL has a five-year survival rate of around 83%, although it drops under 70% in those over 75.
Chronic Lymphocytic Leukemia (CLL) This form of leukemia mostly affects adults over the age of 55. The relative 5-year survival rate for people of all ages with this form of leukemia is 88.5%.
The five-year survival rate for CLL in the United States is 85.7 percent. This means that, for every 100 people diagnosed with CLL now, about 86 people are expected to be alive in five years. This survival rate also applies to people with small lymphocytic lymphoma (SLL).
The 5-year survival rate for adults with CLL ages 20 and older is around 87 percent. This means that 87 percent of people with the condition are alive 5 years after diagnosis. However,...
CLL is the most commonly diagnosed form of leukemia that affects adults, accounting for 25 to 30% of all leukemia diagnoses in the U.S. People are typically diagnosed after age 40, although it’s most common among adults aged 70 and older.
Factors that may increase the risk of chronic lymphocytic leukemia include: Your age. This disease occurs most often in older adults. Your race. White people are more likely to develop chronic lymphocytic leukemia than are people of other races. Family history of blood and bone marrow cancers.
Chronic lymphocytic leukemia (CLL) is a chronic lymphoproliferative disorder (lymphoid neoplasm) characterized by the progressive accumulation of functionally incompetent lymphocytes, which are usually monoclonal in origin.
Find details on chronic lymphocytic leukemia's outlook – including life expectancy and phases of the CLL journey. Learn about diagnosis, "watch and wait," and doctor discussions.